{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T15:10:07Z","timestamp":1793286607483,"version":"4.5.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.cbi.2024.111305","type":"journal-article","created":{"date-parts":[[2024,11,3]],"date-time":"2024-11-03T15:00:21Z","timestamp":1730646021000},"page":"111305","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Exploring the mechanism of ursolic acid in preventing liver fibrosis and improving intestinal microbiota based on NOX2\/NLRP3 inflammasome signaling pathway"],"prefix":"10.1016","volume":"405","author":[{"given":"Qi","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin-Xiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bi-Min","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Kai","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2024.111305_bib1","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/s41580-021-00373-7","article-title":"Liver regeneration and inflammation: from fundamental science to clinical applications","volume":"22","author":"Campana","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.cbi.2024.111305_bib2","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/S0140-6736(21)01374-X","article-title":"Liver cirrhosis","volume":"398","author":"Gines","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.cbi.2024.111305_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.730176","article-title":"Liver fibrosis: therapeutic targets and advances in drug therapy","volume":"9","author":"Tan","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.cbi.2024.111305_bib4","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","article-title":"Molecular and cellular mechanisms of liver fibrosis and its regression","volume":"18","author":"Kisseleva","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.cbi.2024.111305_bib5","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","article-title":"Mechanisms of hepatic stellate cell activation","volume":"14","author":"Tsuchida","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.cbi.2024.111305_bib6","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/hep.32285","article-title":"Hepatic fibrosis 2022: unmet needs and a blueprint for the future","volume":"75","author":"Friedman","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.cbi.2024.111305_bib7","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.matbio.2018.04.006","article-title":"Liver fibrosis: direct antifibrotic agents and targeted therapies","volume":"68\u201369","author":"Schuppan","year":"2018","journal-title":"Matrix Biol."},{"key":"10.1016\/j.cbi.2024.111305_bib8","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1152\/physrev.00044.2005","article-title":"The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology","volume":"87","author":"Bedard","year":"2007","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.cbi.2024.111305_bib9","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.sbi.2019.03.001","article-title":"Structure and mechanisms of ROS generation by NADPH oxidases","volume":"59","author":"Magnani","year":"2019","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.cbi.2024.111305_bib10","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.chom.2016.04.007","article-title":"Defensive mutualism rescues NADPH oxidase inactivation in gut infection","volume":"19","author":"Pircalabioru","year":"2016","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.cbi.2024.111305_bib11","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1038\/s41467-017-02325-2","article-title":"Pro-inflammatory hepatic macrophages generate ROS through NADPH oxidase 2 via endocytosis of monomeric TLR4-MD2 complex","volume":"8","author":"Kim","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cbi.2024.111305_bib12","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3389\/fphys.2016.00017","article-title":"The role of NADPH oxidases (NOXs) in liver fibrosis and the activation of myofibroblasts","volume":"7","author":"Liang","year":"2016","journal-title":"Front. Physiol."},{"key":"10.1016\/j.cbi.2024.111305_bib13","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1053\/j.gastro.2010.05.074","article-title":"Reduced nicotinamide adenine dinucleotide phosphate oxidase 2 plays a key role in stellate cell activation and liver fibrogenesis in vivo","volume":"139","author":"Jiang","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cbi.2024.111305_bib14","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/hep.22708","article-title":"Deficiency of nicotinamide adenine dinucleotide phosphate, reduced form oxidase enhances hepatocellular injury but attenuates fibrosis after chronic carbon tetrachloride administration","volume":"49","author":"Aram","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.cbi.2024.111305_bib15","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1002\/hep.24281","article-title":"The nicotinamide adenine dinucleotide phosphate oxidase (NOX) homologues NOX1 and NOX2\/gp91(phox) mediate hepatic fibrosis in mice","volume":"53","author":"Paik","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.cbi.2024.111305_bib16","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.jhep.2012.03.035","article-title":"Inflammasomes in liver diseases","volume":"57","author":"Szabo","year":"2012","journal-title":"J. Hepatol."},{"key":"10.1016\/j.cbi.2024.111305_bib17","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","article-title":"The NLRP3 inflammasome: molecular activation and regulation to therapeutics","volume":"19","author":"Swanson","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cbi.2024.111305_bib18","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1002\/hep.26592","article-title":"NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice","volume":"59","author":"Wree","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.cbi.2024.111305_bib19","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.jhep.2017.01.022","article-title":"NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice","volume":"66","author":"Mridha","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.cbi.2024.111305_bib20","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1002\/hep.29523","article-title":"NLRP3 inflammasome driven liver injury and fibrosis: roles of IL-17 and TNF in mice","volume":"67","author":"Wree","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.cbi.2024.111305_bib21","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cyto.2015.06.017","article-title":"The interleukin (IL)-1 cytokine family--Balance between agonists and antagonists in inflammatory diseases","volume":"76","author":"Palomo","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.cbi.2024.111305_bib22","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.redox.2015.07.009","article-title":"Genetic disorders coupled to ROS deficiency","volume":"6","author":"O'Neill","year":"2015","journal-title":"Redox Biol."},{"key":"10.1016\/j.cbi.2024.111305_bib23","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.freeradbiomed.2017.02.034","article-title":"Serotonin disturbs colon epithelial tolerance of commensal E. coli by increasing NOX2-derived superoxide","volume":"106","author":"Banskota","year":"2017","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.cbi.2024.111305_bib24","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.jhep.2010.10.040","article-title":"Ursolic acid ameliorates hepatic fibrosis in the rat by specific induction of apoptosis in hepatic stellate cells","volume":"55","author":"Wang","year":"2011","journal-title":"J. Hepatol."},{"key":"10.1016\/j.cbi.2024.111305_bib25","doi-asserted-by":"crossref","first-page":"431","DOI":"10.3389\/fphar.2019.00431","article-title":"Interaction mechanisms between the NOX4\/ROS and RhoA\/ROCK1 signaling pathways as new anti- fibrosis targets of ursolic acid in hepatic stellate cells","volume":"10","author":"Huang","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.cbi.2024.111305_bib26","doi-asserted-by":"crossref","first-page":"6799","DOI":"10.1002\/jcp.26541","article-title":"Ursolic acid ameliorates CCl4-induced liver fibrosis through the NOXs\/ROS pathway","volume":"233","author":"Gan","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.cbi.2024.111305_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109321","article-title":"Ursolic acid alleviates Kupffer cells pyroptosis in liver fibrosis by the NOX2\/NLRP3 inflammasome signaling pathway","volume":"113","author":"Wan","year":"2022","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.cbi.2024.111305_bib28","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1007\/s00204-015-1543-4","article-title":"Experimental models of liver fibrosis","volume":"90","author":"Yanguas","year":"2016","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.cbi.2024.111305_bib29","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1136\/gutjnl-2021-325150","article-title":"FSTL1 promotes liver fibrosis by reprogramming macrophage function through modulating the intracellular function of PKM2","volume":"71","author":"Rao","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.cbi.2024.111305_bib30","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1136\/gutjnl-2018-317872","article-title":"Glial cell line-derived neurotrophic factor (GDNF) mediates hepatic stellate cell activation via ALK5\/Smad signalling","volume":"68","author":"Tao","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.cbi.2024.111305_bib31","doi-asserted-by":"crossref","first-page":"14","DOI":"10.5858\/arpa.2014-0153-RA","article-title":"Application of immunohistochemistry in gastrointestinal and liver neoplasms: new markers and evolving practice","volume":"139","author":"Chen","year":"2015","journal-title":"Arch. Pathol. Lab Med."},{"key":"10.1016\/j.cbi.2024.111305_bib32","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1021\/acs.chemrev.8b00257","article-title":"Highly sensitive and multiplexed protein measurements","volume":"119","author":"Cohen","year":"2019","journal-title":"Chem. Rev."},{"key":"10.1016\/j.cbi.2024.111305_bib33","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1089\/ars.2013.5619","article-title":"Role of NADPH oxidases in liver fibrosis","volume":"20","author":"Paik","year":"2014","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.cbi.2024.111305_bib34","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/cbf.3351","article-title":"Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (NOX) and liver fibrosis: a review","volume":"36","author":"Mortezaee","year":"2018","journal-title":"Cell Biochem. Funct."},{"key":"10.1016\/j.cbi.2024.111305_bib35","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1111\/jgh.14979","article-title":"Exogenous 8-hydroxydeoxyguanosine ameliorates liver fibrosis through the inhibition of Rac1-NADPH oxidase signaling","volume":"35","author":"Shin","year":"2020","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.cbi.2024.111305_bib36","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1038\/s41423-018-0032-0","article-title":"Increased Tim-3 expression alleviates liver injury by regulating macrophage activation in MCD-induced NASH mice","volume":"16","author":"Du","year":"2019","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.cbi.2024.111305_bib37","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jhep.2020.07.041","article-title":"Hepatocyte pyroptosis and release of inflammasome particles induce stellate cell activation and liver fibrosis","volume":"74","author":"Gaul","year":"2021","journal-title":"J. Hepatol."},{"key":"10.1016\/j.cbi.2024.111305_bib38","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.foodchem.2016.10.029","article-title":"Ursolic acid from apple pomace and traditional plants: a valuable triterpenoid with functional properties","volume":"220","author":"Cargnin","year":"2017","journal-title":"Food Chem."},{"key":"10.1016\/j.cbi.2024.111305_bib39","doi-asserted-by":"crossref","first-page":"956","DOI":"10.3389\/fphys.2019.00956","article-title":"Protective effect of ursolic acid on the intestinal mucosal barrier in a rat model of liver fibrosis","volume":"10","author":"Zhang","year":"2019","journal-title":"Front. Physiol."},{"key":"10.1016\/j.cbi.2024.111305_bib40","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/s41575-018-0099-1","article-title":"Alcohol, liver disease and the gut microbiota","volume":"16","author":"Bajaj","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.cbi.2024.111305_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106348","article-title":"Microbiota diversity in nonalcoholic fatty liver disease and in drug-induced liver injury","volume":"182","author":"Rodriguez-Diaz","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.cbi.2024.111305_bib42","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/s41392-022-01119-3","article-title":"Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver\/steatohepatitis (NAFL\/NASH)","volume":"7","author":"Xu","year":"2022","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.cbi.2024.111305_bib43","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/nbt.2942","article-title":"An integrated catalog of reference genes in the human gut microbiome","volume":"32","author":"Li","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.cbi.2024.111305_bib44","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1136\/gutjnl-2019-320204","article-title":"Interaction between drugs and the gut microbiome","volume":"69","author":"Weersma","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.cbi.2024.111305_bib45","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.jhep.2013.01.003","article-title":"Modulation of the fecal bile acid profile by gut microbiota in cirrhosis","volume":"58","author":"Kakiyama","year":"2013","journal-title":"J. Hepatol."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279724004514?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279724004514?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,8]],"date-time":"2024-12-08T17:11:33Z","timestamp":1733677893000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279724004514"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":45,"alternative-id":["S0009279724004514"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2024.111305","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring the mechanism of ursolic acid in preventing liver fibrosis and improving intestinal microbiota based on NOX2\/NLRP3 inflammasome signaling pathway","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2024.111305","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111305"}}